Provided By PR Newswire
Last update: Mar 21, 2025
Strategic Acquisition of Intellectual Property of BRII-179, a Wholly Owned Phase 2b Asset Capable of Combining with Multiple HBV Treatment Modalities for Cure
VIR BIOTECHNOLOGY INC
NASDAQ:VIR (7/28/2025, 8:00:02 PM)
5.48
-0.17 (-3.01%)
Find more stocks in the Stock Screener